BioSpace News Archive

Medtronic plc (NYSE:MDT), a global leader in structural heart therapies, today announced it will begin a randomized, head-to-head study comparing two transcatheter aortic valve replacement (TAVR) systems in patients

Podimetrics, a virtual care management company with the leading solution to help prevent costly and deadly diabetic amputations, today announced results from its latest study of patients at high risk of developing diabetic foot complications, which saw major amputations completely eliminated and all-cause hospital admissions drop by 52 percen

PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“PRIMO” or the “Company”) Primo Nutraceuticals Inc. has entered intoa non-binding letter of intent (the “LOI”) with MedCanBiotechnologies Inc. (“MEDCAN BIOTECH”).

Cerner Corporation (Nasdaq: CERN) today announced it will release its third quarter 2020 earnings results after the market closes Wednesday, October 28th

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer announced today that the U.S. Food and Drug Administration (“FDA”) has cleared the Company’s Investigational New Drug (“IND”) application for 177Lu-omburtamab-DTPA

VivaLNK, a leading provider of connected healthcare solutions, and AMPS, the world leader in the production of software tools for electrocardiogram (ECG), have partnered to advance Remote Patient Monitoring (RPM) for clinical trials

A recently published scientific study led by the Centre for Neurology Studies at HealthTech Connex and a research team from Simon Fraser University (SFU), reports the latest breakthroughs from Project Iron Soldier. Captain (retired) Trevor Greene,

Aiforia, a leading provider of deep learning artificial intelligence (AI) solutions for image analysis across a variety of medical domains, has been granted U.S. Patent No. 10,803,586 by the United States Patent and Trademark Office (USPTO).

Nestlé Health Science, a globally recognized leader in the field of nutritional science, announced today the launch of Celltrient™ Cellular Nutrition, a breakthrough and comprehensive range of nutritional solutions that work cell by cell.

Shasqi, a clinical-stage biotechnology company developing precision activated oncology therapeutics with its proprietary Click Activated Protodrugs Against Cancer (CAPAC™) Platform, announced today the first-ever application of click chemistry in humans, with the launch of the Company’s lead clinical candidate, SQ3370.